PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,935 | -5.7% | 24,690 | +26.6% | 0.00% | -33.3% |
| Q2 2023 | $68,835 | -36.2% | 19,500 | -44.1% | 0.00% | -25.0% |
| Q1 2023 | $107,841 | -45.6% | 34,900 | -25.5% | 0.00% | -63.6% |
| Q4 2022 | $198,108 | +73.8% | 46,834 | +18.0% | 0.01% | +120.0% |
| Q1 2022 | $114,000 | -17.4% | 39,700 | -12.6% | 0.01% | -44.4% |
| Q4 2021 | $138,000 | -40.5% | 45,400 | +97.4% | 0.01% | -80.9% |
| Q3 2020 | $232,000 | – | 23,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |